Main content starts here, tab to start navigating
a man wearing glasses and a blue shirt

Michael Kellick, BS/MS Pharm, PharmD


Dr. Michael Kellick has over 43 years of experience in Pediatric Hematology/Oncology Pharmacy with extensive patient care work and on both institutional and Cooperative Group research efforts.  Dr. Kellick has been a co-investigator on numerous clinical trials.  Dr. Kellick has retired in 2018 from Memorial Sloan Kettering Cancer Center where he served as the Clinical Coordinator for Pediatric Pharmacy Practice.  

He has served as the lead pharmacist for the Pediatric Oncology Experimental Therapeutic Investigators Consortium (POETIC).  He has also served as Chair of the CCG Pharmacy Committee and Vice Chair of the COG Pharmacy Committee. Dr. Kellick has made significant contributions to the Children's Oncology group having served as lead writer of the CCG and subsequently the COG Pharmacy Committee's Protocol Review Guidelines and as a Co-author of the COG Chemotherapy Administration Guidelines.  

Although retired, currently, Dr. Kellick is a board member of the National Cancer Institute’s Central Institutional Review Board (CIRB) since 2012. He reviews treatment protocols for the Children’s Oncology Group, Pediatric Brain Tumor Consortium and the Pediatric Cancer Immunotherapy Trials Network. He is also a volunteer in the development of the International Childrens Cancer Research Center, to be built in Ghana.

Dr. Kellick holds the following professional degrees: Bachelor of Science degree in Pharmacy from the State University of Buffalo; Master of Science degree in Pharmacy from St John’s University and Doctor of Pharmacy from the University of Florida.